Predictive Value of the (Quick)DASH Tool for Upper Extremity Dysfunction Following Percutaneous Coronary Intervention.

Purpose: The use of the Disability of the Arm, Shoulder and Hand (DASH) questionnaire and its shortened version, the QuickDASH, have been used to assess upper extremity function following a transradial percutaneous coronary intervention (TR-PCI). However, the use of these scores has not yet been validated for TR-PCI induced complications in the upper extremity. The aim of this study was to establish the validity of the DASH and the QuickDASH, for the assessment of upper extremity dysfunction following a transradial percutaneous coronary intervention (TR-PCI). Patients and
Methods: This study was a diagnostic retrospective analysis of the ARCUS study, of whom 440 underwent TR-PCI and 62 control patients were treated via the transfemoral approach. All participants completed the DASH and QuickDASH questionnaire prior to the procedure and at each follow-up visit up to six months of follow-up. Receiver operating characteristics (ROC) were constructed to determine the validity of the questionnaires, using physical examinations to determine the occurrence of upper extremity dysfunction, according to the ARCUS study.
Results: At each follow-up moment, the area under the curve (AUC) showed a poor ability of the DASH and QuickDASH to discriminate between patients with and without upper extremity dysfunction (AUC: 0.565-0.586). There was no significant difference between the questionnaires (p > 0.05).
Conclusion: The DASH and QuickDASH questionnaires are both equally incapable of discriminating between patients with and without upper extremity dysfunction following a TR-PCI. Study results suggest that the DASH and QuickDASH questionnaires are incapable of discerning changes in upper extremity function as a result of procedural complications following a TR-PCI vs cardiac induced activity cessation.

Introduction

The Disability of the Arm, Shoulder and Hand (DASH) questionnaire is a 30-item, patient-reported questionnaire that measures physical function and symptoms in people with musculoskeletal disorders of the upper extremity.1–3 The shortened version, the QuickDASH, an 11-item questionnaire, was designed to improve practicality and item redundancy.4,5 A few examples of conditions where the QuickDASH can be used with similar precision as the DASH are as follows: Carpal Tunnel Syndrome, ganglion- and shoulder disorders.6,7

Transradial Percutaneous Coronary Intervention (TR-PCI) has become the gold standard in treating coronary artery stenosis.8 Transfemoral approach is an alternative access route when a patient presents with (relative) contra-indications for TR-PCI: eg previously failed transradial approach or radial artery occlusion. Compared to femoral access, in patients with ST-Segment Elevation Myocardial Infarction (STEMI), radial access caused 73% less major access bleeding, with a trend towards reduction of mortality and ischemic events.9

The QuickDASH has been used to assess the upper extremity function following TR-PCI.10–12 The use of these patient-reported outcome measures (PROMs), however, has not yet been validated for TR-PCI induced complications in the upper extremity. The objective of this analysis was to establish the validity of the DASH and QuickDASH questionnaires for the assessment of upper extremity dysfunction (UED) following TR-PCI. Furthermore, the validity and interchangeability of these PROMs were assessed. We hypothesized that patients undergoing TR-PCI without UED would report similar (Quick)DASH scores when compared to patients with UED.

Materials and Methods

This study is a retrospective sub-analysis of the Effects of trAnsRadial perCUtaneouS coronary intervention on upper extremity function (ARCUS) study, a multicenter prospective cohort study performed in the Netherlands, providing insight into access-site morbidity and UED following TR-PCI.13,14 The upper extremity function following a TR-PCI was assessed using a combination of objective measurements (eg strength and sensibility measurements) and the DASH.14

Patients were included in the ARCUS study, if they presented for a percutaneous coronary intervention, had a palpable radial artery, and if Doppler ultrasound examination confirmed a non-occluded flow. Patients underwent clinical assessments of the upper extremity and completed two self-administered questionnaires (the DASH and Numeric Rating Scale for Pain (NRSP) prior to the index procedure. Procedures using the contralateral radial artery or femoral artery after previous unsuccessful attempts were also included in this study.13

Exclusion criteria were 1) absence of informed consent, 2) an absent signal of the radial artery objectified by Doppler ultrasound, 3) illiteracy, and 4) incapability to accomplish measurements due to comorbidities.

Questionnaires

The NRSP and the DASH were evaluated on the day of the procedure, and at 2-week, 1-month, and 6-months of follow-up. The NRSP has an 11-point scale, from “0: no pain at all” to “10: worst imaginable pain”.15 The DASH questionnaire consists of 30-items: 24 items to assess function/disability and six items to measure symptoms.16 Each item is scored on a five-point scale. The total of the item-scores are used to calculate the DASH score ranging from 0 to 100, with a higher DASH score indicating a poorer level of function.3

The 11-items that comprise the QuickDASH were extracted from the DASH questionnaire and had the same five-point scale per item.4,5 The QuickDASH has eight function/disability items and three symptom items.4

Reference Test for Upper Extremity Function

The physical status of the upper extremity was examined by assessing tactile sensation using the Weinstein Enhanced Sensory Test (WEST), with results presented on a five-point scale (1: 0.05 gr; 2: 0.20 gr; 3: 2.00 gr; 4: 4.00 gr; 5: 300.0 gr).17 The palmar grip and key-pinch strength measurements were measured using a Jamar hydraulic hand dynamometer and Jamar hydraulic pinch gauge (Jamar, Performance Health, Warrenville, Illinois, United States).18 Isometric strength of flexion and extension of the elbow and wrist were assessed using the microFET2 digital handheld dynamometer (microFET2, Hogan Scientific, Salt Lake City, Utah, United States).19 For both arms, the palmar grip, key-pinch and isometric strength were documented as the mean of three repeated measurements. Additionally, the circumference of the hand was measured using a figure-of-eight method, whereas circumference of the forearm was measured circumferentially at eight cm distal of the medial epicondyle of the humerus, both noted in centimeters.20,21

All examinations were performed by a dedicated study member, trained and certified by a hand rehabilitation specialist. Clinical information and (Quick)DASH results were available to the investigators who performed the clinical assessment of the upper extremity.

A precise and published definition of upper extremity function does not exist, therefore hand experts tried to capture a definition for upper extremity function with the help of several examinations, performed according to the American Society of Hand Therapist (ASHT).22 A binary score, absence or presence of UED, was composed out of eight pre-specified criteria. The presence of the UED is defined as ≥2 criteria present as specified in Table 1.14

Table 1

Upper Extremity Dysfunction Criteria

Increased NRSP score regarding the upper extremity of ≥ 2 points

Absent signal of the radial artery during Doppler ultrasound examination

Strength:

≥ 15% decrease in palmar grip strength

≥ 15% decrease in key grip strength

≥ 15% decrease in isometric strength of flexion and extension of the elbow and wrist

≥ 2 filaments increase in sensibility of the hand according to the WEST

≥ 2 cm increase of circumference of the hand, using the figure-of-eight method

≥ 2 cm increase of circumference of the forearm, measured circumferentially 8 cm distal of the medial epicondyle

Note: For the primary endpoint, a positive score for Upper Extremity Dysfunction is defined as having ≥ 2 criteria, at 2 week follow-up.

Abbreviations: NRSP, numeric rating scale for pain; WEST, Weinstein enhanced sensory test.

Procedure

All patients were treated with conventional 6 French introducer sheaths and catheters, after which non-patent hemostasis of the radial artery was achieved by using a compression device (Terumo Medical Corporation, Japan). For the transfemoral group, an implantable device (Angio-Seal) was used to achieve hemostasis. Complications were noted during the procedure and clinical outpatient visits, and when necessary, patients were referred to a hand specialist.

Handling of Incomplete Responses

For this sub-analysis, only patients with complete baseline data for the questionnaires and clinical assessments were included. A minimum of, respectively, 27 or 10 completed items of the DASH and QuickDASH was required to consider the questionnaires complete.7 An incomplete questionnaire resulted in exclusion from the analysis.

Data Analysis

Descriptive statistics were provided for all variables. Results were presented as mean with standard deviation (SD), counts, and/or percentages. Non-normally distributed results were presented as median with interquartile range (IQR). The baseline and follow-up scores for the (Quick)DASH were calculated for the transradial and transfemoral approach group. Between-group differences of dichotomous variables were analyzed using Chi-square test with Yates continuity correction. Categorical variables with at least two categories were analyzed with the Pearson’s chi-squared test. For normally distributed variables, an independent sample t-test was used, and for continuous variables that were not normally distributed, the Mann–Whitney U-test was applied. A Spearman rank test was performed to evaluate the correlation between changing (Quick)DASH scores and the severity of UED.

To study the validity of the scoring of the (Quick)DASH, the extracted scores were correlated to the upper extremity function as was found during the physical examination.

Receiver operating characteristics (ROC) were constructed using change in (Quick)DASH scores (baseline vs follow-up) as the test variable and patients’ UED status (“UED” and “no UED”) as the classifying variable (Table 1).23 The difference in the areas under the ROC curves (AUC) for the two questionnaires was compared for each consecutive follow-up moment. An AUC of approximately (0.5), suggested no discrimination between patients with and without UED, 0.7–0.8 was considered acceptable, 0.8–0.9 was considered excellent, and an AUC exceeding 0.9 was considered outstanding.23

The minimal clinically important difference (MCID) score that corresponds to a clinically relevant decrease in upper extremity function was an increase exceeding 15 points for the DASH questionnaire and eight points for the QuickDASH questionnaire, respectively.24–26 Differences in the occurrence of a score greater than the MCID thresholds between the UED group and non-UED group and between the referral and no referral group were analyzed with Pearson’s chi-squared test.

All the tests were two-sided, with a statistical significance level set at 5%. Statistical analyses were performed with SPSS for Apple version 26 (IBM Corp, Armonk, NY) and R Statistics for Apple version 3.6.2 (The R Foundation, Austria).

The ARCUS study was conducted in accordance with the Declaration of Helsinki and was approved by the regional ethics committee “Toetsingscommissie Wetenschappelijk Onderzoek” (TWOR) (Rotterdam, the Netherlands). The TWOR has been merged with the regional ethics committee “Medical Research Ethics Committees United” (MEC-U) in 2019 (Nieuwegein, the Netherlands) (NL45613.101.13). All TWOR research files have been taken over by the MEC-U. The ARCUS study was registered at ClinicalTrials.gov (NCT02204423).

For this sub-analysis, permission was obtained to utilize data gathered through the ARCUS study. Written informed consent was obtained before study participation, including consent to be published. All patient data were anonymised and stored for at least 15 years at the study site.

Results

All procedures were performed between January 2014 and July 2018. Five hundred and two patients were included in the ARCUS study of whom 440 underwent an elective intervention via the transradial approach (TRA) and 62 via the transfemoral approach (TFA). Five patients were considered ineligible because they did not meet the inclusion criteria. Figure 1 shows the patient enrollment flowchart. Complete baseline data on the DASH and QuickDASH questionnaires were obtained from 463 patients. In 34 (6.8%) patients, baseline questionnaire data were incomplete. Incomplete or absent questionnaire data was caused by subject withdrawal or lost to follow-up (Figure 1). The transradial and transfemoral groups were similar in all baseline characteristics except for family history of heart disease (Table 2).

Figure 1

Study enrolment flow chart.

Table 2

Baseline Characteristics of the Study Sample

	Total Sample	Transradial	Transfemoral (Control)	P-value
	N = 463	N = 407	N = 56
Men	367 (79.3%)	322 (79.1%)	45 (80.4%)	0.969
Age, y	65.3±10.1	65.2±10.1	66.2±10.6	0.474
Body mass index	27.8±4.4	27.8±4.3	27.5±5.0	0.574
Height	175.4±9.2	175.6 ±9.2	174.6±9.3	0.456
Smoking
Current	76 (16.4%)	69 (17.0%)	7 (12.5%)	0.367
Previous	237 (51.2%)	210 (51.6%)	27 (48.2%)
Never	149 (32.2%)	127 (31.2%)	22 (39.3%)
Hypertension	250 (54.0%)	224 (55.0%)	26 (46.4%)	0.277
Hypercholesterolemia	196 (42.3%)	165 (40.5%)	31 (55.4%)	0.052
Diabetes Mellitus	104 (22.5%)	89 (21.9%)	15 (26.8%)	0.518
Family history of heart disease	230 (49.7%)	195 (47.9%)	35 (62.5%)	0.031
Pre-existent hand disease of intervention arm	209 (45.1%)	182 (44.7%)	27 (48.2%)	0.762
Previous transradial PCI	217 (46.9%)	189 (46.4%)	28 (50.0%)	0.745
Right hand dominance	413 (89.2%)	361 (88.7%)	52 (92.9%)	0.534

Notes: Values are means ± SD, medians ± IQR, or n (%). The tests used for the comparison between the Transradial and Control group were as follows: Chi-square test with Yates Continuity Correction for categorical data, independent samples t-test for normally distributed continuous variables, and Mann–Whitney U-test for not normally distributed variables.

Abbreviations: IQR, interquartile range; PCI, percutaneous coronary intervention; SD, standard deviation.

Upper Extremity Dysfunction

A total of 96 (32.7%) patients in the transradial group developed UED after 2-week follow-up vs five patients (13.9%) in the transfemoral group (p = 0.03). This evolved to 99 patients (32.0%) at 1-month follow-up in the transradial group and 14 patients (31.8%) in the transfemoral group (p = 1.00). At 6-months follow-up 134 patients (44.4%) in the transradial group and 24 patients (57.1%) in the transfemoral group developed UED (p = 0.16).

Questionnaire Scores

The median DASH score at baseline in the total study population was 0.83 (IQR 7.28). The median baseline QuickDASH score was 0.00 (IQR 9.09). The median DASH score at baseline and at 2-week follow-up was significantly higher in the radial group vs the transfemoral control group (p < 0.05) (Table 3). Similar results were observed when the baseline QuickDASH score was compared between the radial- and transfemoral control groups (p < 0.01) (Table 3). A Mann–Whitney U-test revealed a significant difference for both DASH and QuickDASH scores at two weeks, at the disadvantage of the transradial group, as they had higher scores for disability (Table 3).

Table 3

DASH and QuickDASH Score Between the Transradial Group and Transfemoral Group

	Radial		Femoral (Control)
	DASH	QuickDASH	DASH	QuickDASH	P-value DASH	P-value QuickDASH
Baseline	0.83 (7.75)	0.00 (11.36)	0.00 (1.87)	0.0 (2.27)	0.014	0.001
2 Week	1.67 (10.00)	2.27 (11.36)	0.00 (3.33)	0.0 (4.55)	0.003	0.003
1 Month	0.00 (8.33)	0.00 (9.09)	0.00 (6.81)	0.0 (5.00)	0.233	0.365
6 Months	0.83 (10.00)	0.00 (11.36)	0.83 (4.79)	0.0 (4.55)	0.574	0.278

Notes: Values are median (IQR). The difference in (Quick)DASH score between the transradial group and transfemoral group was analyzed using the Mann–Whitney U-Test.

Abbreviations: DASH, Disability of the Arm, Shoulder and Hand; IQR, interquartile range.

The correlation coefficient between the change in DASH or QuickDASH score (difference baseline-follow-up) and UED severity was 0.14 (p = 0.02) and 0.16 (p = 0.006), respectively, at 2-week follow-up. At 1-month follow-up, a correlation coefficient of 0.12 (p = 0.03) and 0.14 (p = 0.01) was found for the DASH and QuickDASH scores, respectively. At 6-months follow-up, the correlation coefficient was 0.13 (p = 0.02) and 0.12 (p = 0.02) for the DASH and QuickDASH, respectively. All correlation coefficients indicate a very weak association between increasing DASH and QuickDASH scores with UED severity.

There was a significant difference between the UED and non-UED group, in the occurrence of a DASH score increase (baseline – follow-up) exceeding the MCID threshold (>15 points) at 1-month (11.2% vs 2.8%, respectively, p = 0.01) and 6-months follow-up (12.2% vs 4.1%, respectively, p = 0.01) (Table 4). For the QuickDASH, a significant difference between the UED and non-UED groups in a score exceeding the MCID threshold (>8 points) was found at 2-week and 6-months follow-up (p < 0.001) (Table 4).

Table 4

Difference in the Occurrence of a Score Greater Than the MCID* Threshold Between the UED Group and Non-UED Group

		UED	Non-UED	P-value
2 Week Follow-up	DASH	4 (4.7)	6 (2.9)	0.67
	QuickDASH	23 (26.1)	19 (9.2)	< 0.001
1 Month Follow-up	DASH	11 (11.2)	6 (2.8)	0.01
	QuickDASH	13 (13.1)	16 (7.4)	0.16
6 Months Follow-up	DASH	17 (12.2)	7 (4.1)	0.01
	QuickDASH	33 (23.9)	14 (8.2)	< 0.001

Notes: Values are n (%). *The MCID thresholds are as follows: DASH (> 15 points increase) and QuickDASH (> 8 points increase). Chi-square test with Yates Continuity Correction was used to compare patients with- and without UED with a (Quick)DASH score greater than the MCID threshold.

Abbreviations: DASH, Disability of the Arm, Shoulder and Hand; MCID, minimal clinically important difference; UED, upper extremity dysfunction.

Referred Patients

The referral rate to a hand specialist during the total follow-up period was 18%: four subjects at day of procedure, 24 subjects at 2-week follow-up, 23 subjects at 1-month follow-up and 28 subjects at 6-months follow-up.

When comparing the referred group to the non-referred group, a significant difference in DASH score increase (baseline – follow-up) exceeding the MCID (>15 points), was found at 1-month follow-up (36.7% vs 4.6%, respectively, p < 0.001) and 6-months follow-up (28.6% vs 6.8%, respectively, p = 0.002). For the QuickDASH, a significant difference in the occurrence of a MCID (>8 points) between the referred- and the non-referred group was found at every executive follow-up moment: 2-week follow-up (50.0% vs 11.8%, respectively, p < 0.001), 1-month follow-up (47.4% vs 10.1%, respectively, p < 0.001) and 6-months follow-up (56.5% vs 13.5%, respectively, p = 0.002).

Diagnostic Ability of the DASH and QuickDASH

The AUC of the DASH and QuickDASH for UED was 0.566 and 0.586, respectively, at 2-week follow-up (Figure 2). These scores indicate a poor ability to discriminate between patients with- and without UED (Figure 2). The AUC was 0.565 and 0.565 at 1-month follow-up and 0.578 and 0.576 at 6-months of follow-up, for the DASH and QuickDASH, respectively.

Figure 2

Receiver-operating-characteristic (ROC) curves for upper extremity with the DASH and QuickDASH score.

The difference in the AUC between the DASH and QuickDASH at 2-week follow-up was 0.02 (p = 0.73), indicating that both questionnaires were equally incapable of discriminating between patients with- and without UED (Figure 2). At 1-month follow-up, the difference in the AUC for the DASH and QuickDASH was 0.00 (p = 1.00) and the difference in the AUC at 6-months follow-up was −0.002 (p = 0.96) between the DASH and QuickDASH (Figure 2).

Discussion

This study investigated the validity of the DASH and QuickDASH in the evaluation of post-PCI upper extremity dysfunction, controlled by objective functional measurements. Both objective measurements and self-reported questionnaires indicated that PCI does affect upper extremity function.

In contrast to previously published literature, the UED at two weeks following TR-PCI as measured in our study increased significantly over time, and showed a significant difference in occurrence of UED between the transradial and transfemoral approaches.10,11 Furthermore, referral to a hand specialist was arranged in 18% patients during follow-up, indicating clinically relevant complaints. The DASH questionnaire was chosen because the individual’s quality of life and ability to do activities regardless of which upper extremity they use is also of interest.1

The considerable number of patients with complaints in the control group can be explained by an increased focus and awareness in study subjects regarding the upper extremity function. This could lead to excessive referral, which is most likely not a result of TR-PCI.

The high number of patients with complaints in both groups could also be explained by the initial reaction to anxiety following a myocardial infarct. Previous studies consistently report that almost one-fifth of patients experience clinical levels of anxiety and depression symptoms shortly following the myocardial infarct.26–28 Patients with distress are more likely to reduce their everyday activities and physical exercise up to one year after the myocardial infarct.29 Additionally, this distress and anxiety, in combination with delayed access (>4 weeks) to a cardiac rehabilitation program, can result in decreased physical activity, resulting in detraining of the (upper extremity) muscles.30

The DASH and QuickDASH are upper extremity-specific PROMs. A previous study that investigated whether the DASH questionnaire exclusively measured disability associated with upper extremity injuries found that the DASH questionnaire also measured disability in patients with injuries to the lower limb.31 A possible explanation was the healing process following the lower limb injury that interfered with the mobility and stability of the upper limb, for example, by using crutches.31 It was hypothesized that the increased scores of the DASH and the QuickDASH in the transfemoral group represent the overall disability and inactivity in patients with a cardiovascular condition as the primary impairment instead of upper extremity-specific disability. The function items on the QuickDASH refer to heavier tasks requiring greater strength than the function items of the DASH, possibly giving a distorted representation in cardiac patients with impaired exercise capacity. Angst et al demonstrated that the QuickDASH underestimates symptoms but overestimates disability and does not measure the same symptoms content as the DASH.32 The QuickDASH outcome measure is a cut-down version of the DASH, and this shortening raises the question whether the QuickDASH is non-inferior to the DASH and whether excluding 19 items loses too much information.

The increase in DASH and QuickDASH mean scores exceeding the MCID threshold occurred significantly more in referred patients. Similar results were found when comparing UED and non-UED patients. However, according to the MCID, deterioration of upper extremity function was not of clinical relevance in most cases (Table 4).

Additionally, the properties of the shortened QuickDASH as compared to the full-length DASH specifically for UED following PCI were examined. The ROC curves showed that both the DASH and QuickDASH were incapable of discriminating between patients with- and without UED. This suggests that despite a significant increase in scores for patients with UED and patients who were referred, the clinical relevance of this increase is debatable

Care must therefore be taken when attributing disability measured by the DASH and QuickDASH scores to injuries of the upper extremity when myocardial problems are also present. Its inability to discern changes in specific functional aspects of the upper extremity as a result of local complication or physical activity cessation post-PCI must be considered when using this instrument in clinical practice or research.

Limitations

No standard definition of UED exists, therefore a comprehensive definition was designed including all relevant aspects of upper extremity function (eg strength, sensibility, pain symptoms). The definition of UED in this study was designed by hand specialists based on examinations performed according to the ASHT.22 This definition of UED has not been validated.

In our study sample, the DASH and QuickDASH were calculated based on a single set of responses, using the DASH questionnaires proforma. Therefore, intra-observer reproducibility or test–retest reliability is not observed. Furthermore, the response rate was low, creating a risk of unverifiable selection bias. The patients in the present study were only followed for 6 months post intervention, and their DASH scores may not represent final outcomes due to treatment of disease and progressive recovery. However, the methodology of this study was appropriate to fulfill the specific objectives of this study.

Finally, the investigators in this study were not blinded. Information bias was minimized by using standardized physical tests for questionnaire validation. These tests were minimally influenced by the performing investigator.

Conclusion

The use of the DASH and QuickDASH questionnaires for identifying UED after a TR-PCI has been shown to be invalid. Our study results suggest that both PROMS are equally incapable of discerning UED as a result of local complication or physical activity cessation post PCI, and more likely measures post-cardiac intervention induced impaired condition.

The DASH and QuickDASH should not be used for the assessment of access-site complications in the upper extremity following a TR-PCI. It remains important to actively inquire after symptoms and complications following a TR-PCI, especially with occupations depending on manual labor and dexterity influencing patients’ functional independence and quality of life.